GlaxoSmithKline
GSK
#211
Rank
S$132.09 B
Marketcap
S$65.36
Share price
1.78%
Change (1 day)
54.08%
Change (1 year)

Market capitalization of GlaxoSmithKline (GSK)

Market cap: S$132.09 Billion

As of January 2026 GlaxoSmithKline has a market cap of S$132.09 Billion. This makes GlaxoSmithKline the world's 211th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GlaxoSmithKline from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026S$132.09 B3.58%
2025S$127.53 B34.93%
2024S$94.51 B-6.15%
2023S$100.70 B4.43%
2022S$96.43 B-34.62%
2021S$147.50 B21.5%
2020S$121.39 B-22.63%
2019S$156.90 B22.27%
2018S$128.33 B8.89%
2017S$117.85 B-13.57%
2016S$136.36 B-2.68%
2015S$140.11 B1.8%
2014S$137.64 B-15.79%
2013S$163.45 B26.37%
2012S$129.34 B-13.3%
2011S$149.18 B13.66%
2010S$131.25 B-14.74%
2009S$153.94 B11.37%
2008S$138.23 B-30.78%
2007S$199.71 B-14.22%
2006S$232.82 B-5.11%
2005S$245.36 B6.9%
2004S$229.52 B2.59%
2003S$223.73 B14.28%
2002S$195.78 B-31.22%
2001S$284.65 B-6.77%
2000S$305.31 B80.28%
1999S$169.35 B-18.58%
1998S$208.01 B44.18%
1997S$144.27 B83.16%
1996S$78.77 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of GlaxoSmithKline was reported to be:

S$133.31 Billion
by Nasdaq info icon info icon
S$132.09 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
S$384.40 B 191.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
S$187.16 B 41.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$356.83 B 170.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$360.91 B 173.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$149.31 B 13.03%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
S$48.19 B-63.52%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
S$2.35 B-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA